Skip to main content
Premium Trial:

Request an Annual Quote

DNAnexus, Curio Bioscience Ink Deal for Spatial Transcriptomics Data Analysis

NEW YORK – DNAnexus and Curio Bioscience said on Wednesday that they have formed a collaboration to streamline data analysis for high-resolution, whole-transcriptome spatial mapping studies.

Under the partnership, customers of the Curio Seeker Spatial Mapping Kit will be able to use the DNAnexus Precision Health Data Cloud to process Curio Seeker datasets across different tissue types and species.

Financial terms of the deal were not disclosed.

"This collaboration with DNAnexus provides our customers with a fully integrated, easy-to-use, and scalable cloud-based environment for accessing and analyzing the rich, whole-transcriptome, and high-resolution spatial datasets generated by the Curio Seeker workflow," Curio Cofounder and Chief Technology Officer Christina Fan said in a statement.

DNAnexus previously struck a string of similar data analysis collaborations leveraging its Precision Health Data Cloud. In January, the Mountain View, California-based company partnered with TMA Precision Health to integrate the Precision Health Data Cloud and analysis tools with TMA's whole-genome sequencing data with associated longitudinal medical records to advance rare disease research. It also inked an agreement to add Intelliseq's Iflow automated genome interpretation and reporting tool to the Precision Health Data Cloud platform.

Based in Palo Alto, California, Curio Bioscience launched its Seeker platform last year, building on a whole-transcriptome spatial genomics method developed by Fei Chen's lab at the Broad Institute.